Cancers,
Journal Year:
2021,
Volume and Issue:
13(13), P. 3149 - 3149
Published: June 24, 2021
Background:
To
date,
most
researchhas
focused
on
the
bacterial
composition
of
human
microbiota.
In
this
review,
we
synopsize
recent
data
mycobiome
and
cancer,
highlighting
specific
cancer
types
based
current
available
evidence,
presenting
interesting
perspectives
limitations
studies
laboratory
methodologies.
Recent
findings:
Head
neck
carcinoma
(HNCC),
colorectal
(CRC)
pancreatic
ductal
adenocarcinoma
(PDA)
have
been
associated
with
dissimilarities
in
mycobiota
between
cases
non-cancer
participants.
Overall,
fungal
dysbiosis
decreased
richness
diversity
was
common
patients;
however,
a
mycobiotic
signature
HNSCC
or
CRC
has
not
emerged.
Different
strains
Candida
albicans
identified
among
HNCC,
whilst
Lichtheimia
corymbifera,
member
Mucoraceae
family,
shown
to
predominate
patients
oral
tongue
cancer.
Virulence
factors
spp.
include
formation
biofilm
filamentation,
secretion
toxins
metabolites.
present
dysregulated
ratio
Basidiomycota/Ascomycota.
Abundance
Malassezia
linked
occurrence
progression
PDA,
particularly
animal
models
PDA.
Interestingly,
Schizophyllum,
component
mycobiome,
may
exhibit
anti-cancer
potential.
Conclusion:
The
per
se,
along
its
interactions
bacteriome
host,
be
implicated
promotion
carcinogenesis.
Fungi
used
as
diagnostic
prognostic/predictive
tools
treatment
targets
for
coming
years.
More
large-scale,
prospective,
multicentric
longitudinal
an
integrative
multi-omics
methodology
are
required
examine
precise
contribution
etiopathogenesis
delineate
whether
changes
that
occur
causal
consequent
Frontiers in Microbiology,
Journal Year:
2019,
Volume and Issue:
9
Published: Jan. 9, 2019
The
human
microbiome
has
received
decades
of
attention
from
scientific
and
medical
research
communities.
gastrointestinal
tract
is
host
to
immense
populations
microorganisms
including
bacteria,
viruses,
archaea
fungi
(the
gut
microbiota).
High-throughput
sequencing
computational
advancements
provide
unprecedented
ability
investigate
the
structure
function
microbial
communities
associated
with
body
in
health
disease.
Most
date
largely
focused
on
elucidating
bacterial
component
microbiota.
Study
"mycobiota",
which
refers
diverse
array
fungal
species,
a
relatively
new
rapidly
progressing
field.
Though
omnipresent,
number
abundance
occupying
orders
magnitude
smaller
than
that
bacteria.
Recent
insights
however,
have
suggested
mycobiota
may
be
intricately
linked
Evaluation
shown
not
only
are
altered
disease,
but
they
also
play
role
maintaining
intestinal
homeostasis
influencing
systemic
immunity.
In
addition,
it
now
widely
accepted
host-fungi
bacteria-fungi
associations
critical
health.
While
disease
rise,
little
been
performed
context
neuroimmune
neurodegenerative
conditions.
Gut
microbiota
dysbiosis
(specifically
bacteria
archaea)
reported
neurological
diseases
such
as
multiple
sclerosis,
amyotrophic
lateral
sclerosis
Alzheimer's,
among
others.
Given
paucity
mycobiota-specific
studies
this
review
discusses
potential
other
diseases.
Herein,
we
an
overview
recent
advances
mycobiome
discuss
plausible
both
non-intestinal
Communications Biology,
Journal Year:
2021,
Volume and Issue:
4(1)
Published: March 5, 2021
As
an
active
interface
between
the
host
and
their
diet,
gut
microbiota
influences
metabolic
adaptation;
however,
contributions
of
fungi
have
been
overlooked.
Here,
we
investigate
whether
variations
in
mycobiome
abundance
composition
correlate
with
key
features
metabolism.
We
obtained
animals
from
four
commercial
sources
parallel
to
test
if
differing
starting
mycobiomes
can
shape
adaptation
response
processed
diets.
show
that
healthy
mice
is
shaped
by
environment,
including
significantly
correlates
outcomes.
demonstrate
exposure
diet
leads
persistent
differences
fungal
communities
associate
differential
deposition
body
mass
male
compared
fed
standardized
diet.
Fat
liver,
transcriptional
metabolically
tissues
serum
biomarker
levels
are
linked
alterations
community
diversity
composition.
Specifically,
variation
genera
Thermomyces
Saccharomyces
most
strongly
disturbance
weight
gain.
These
data
suggest
host-microbe
interactions
may
be
influenced
variability
mycobiome.
This
work
highlights
potential
significance
health
has
implications
for
human
experimental
studies.
Frontiers in Microbiology,
Journal Year:
2019,
Volume and Issue:
10
Published: Aug. 21, 2019
The
human
gut
is
inhabited
by
diverse
microorganisms
that
play
crucial
roles
in
health
and
disease.
Gut
microbiota
dysbiosis
increasingly
considered
as
a
vital
factor
the
etiopathogenesis
of
irritable
bowel
syndrome
(IBS),
which
common
functional
gastrointestinal
disorder
with
high
incidence
all
over
world.
However,
investigations
to
date
are
primarily
directed
bacterial
community,
mycobiome,
another
fundamental
part
ecosystem,
has
been
underestimated.
Intestinal
fungi
have
important
effects
on
maintaining
homeostasis
just
species.
In
present
article,
we
reviewed
potential
mycobiome
pathogenesis
IBS
connections
between
existing
mechanisms
such
chronic
low-grade
inflammation,
visceral
hypersensitivity,
brain-gut
interactions.
Moreover,
possible
strategies
targeted
at
for
managing
were
also
described.
This
review
provides
basis
considering
role
offers
novel
treatment
patients;
moreover,
it
adds
new
dimensions
researches
microorganism.
Therapeutic Advances in Gastroenterology,
Journal Year:
2021,
Volume and Issue:
14
Published: Jan. 1, 2021
The
gut
microbiome
comprised
of
microbes
from
multiple
kingdoms,
including
bacteria,
fungi,
and
viruses.
Emerging
evidence
suggests
that
the
intestinal
fungi
(the
"mycobiome")
play
an
important
role
in
host
immunity
inflammation.
Advances
next
generation
sequencing
methods
to
study
fecal
samples
mucosa
tissues
have
expanded
our
understanding
homeostasis
systemic
health
their
contribution
different
human
diseases.
In
this
review,
current
status
mycobiome
health,
early
life,
diseases
inflammatory
bowel
disease,
colorectal
cancer,
metabolic
were
summarized.
Cancers,
Journal Year:
2021,
Volume and Issue:
13(13), P. 3149 - 3149
Published: June 24, 2021
Background:
To
date,
most
researchhas
focused
on
the
bacterial
composition
of
human
microbiota.
In
this
review,
we
synopsize
recent
data
mycobiome
and
cancer,
highlighting
specific
cancer
types
based
current
available
evidence,
presenting
interesting
perspectives
limitations
studies
laboratory
methodologies.
Recent
findings:
Head
neck
carcinoma
(HNCC),
colorectal
(CRC)
pancreatic
ductal
adenocarcinoma
(PDA)
have
been
associated
with
dissimilarities
in
mycobiota
between
cases
non-cancer
participants.
Overall,
fungal
dysbiosis
decreased
richness
diversity
was
common
patients;
however,
a
mycobiotic
signature
HNSCC
or
CRC
has
not
emerged.
Different
strains
Candida
albicans
identified
among
HNCC,
whilst
Lichtheimia
corymbifera,
member
Mucoraceae
family,
shown
to
predominate
patients
oral
tongue
cancer.
Virulence
factors
spp.
include
formation
biofilm
filamentation,
secretion
toxins
metabolites.
present
dysregulated
ratio
Basidiomycota/Ascomycota.
Abundance
Malassezia
linked
occurrence
progression
PDA,
particularly
animal
models
PDA.
Interestingly,
Schizophyllum,
component
mycobiome,
may
exhibit
anti-cancer
potential.
Conclusion:
The
per
se,
along
its
interactions
bacteriome
host,
be
implicated
promotion
carcinogenesis.
Fungi
used
as
diagnostic
prognostic/predictive
tools
treatment
targets
for
coming
years.
More
large-scale,
prospective,
multicentric
longitudinal
an
integrative
multi-omics
methodology
are
required
examine
precise
contribution
etiopathogenesis
delineate
whether
changes
that
occur
causal
consequent